AzTrials
AzTrials

Behavior ChangeNCT06593340

Evaluation of Report-Back Strategies for Long-term and Short-term Exposure Information in Rural Tribal Populations

A study testing Messenger 1, Messenger 2 and Format 1 in people with Behavior Change, run by University of Utah.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this study is to evaluate different ways to provide feedback about environmental sampling results to participants. Specifically, the study will look at exposures with long-term risk (radon) and short-term risk (indoor particulate matter, PM2.5). Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Behavior Change
What is being tested?
Messenger 1, Messenger 2 and Format 1
Could I receive a placebo?
No, everyone receives an active treatment
How many people
112 participants
Where
No sites listed yet
Study dates
Oct 2026to Apr 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Enrolled member of the participating tribe

Who cannot join

  • Participant in one of our previous studies

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Darrah K Sleeth, PhD contact

801-585-3587

darrah.sleeth@hsc.utah.edu

Scott Collingwood, PhD contact

801-213-3726

scott.collingwood@hsc.utah.edu

About this study

The goal of this study is to evaluate different ways to provide feedback about environmental sampling results to participants. Specifically, the study will look at exposures with long-term risk (radon) and short-term risk (indoor particulate matter, PM2.5). The hypothesis is that providing feedback in real-time will result in participants engaging in more activities to try to reduce their exposure. One of the main questions of interest is: How does the information messenger impact the effectiveness of report-back strategies in rural, tribal populations?

Participants will have radon and PM2.5 measurement equipment installed at their home and will answer questions about any actions they took to reduce exposure. Previously developed approaches to reporting back those exposures will be used to test which feedback method results in more actions to reduce exposure.

Conditions
Behavior Change
Being tested
Messenger 1, Messenger 2, Format 1, Format 2
Keywords
exposure, Native American, radon, particulate matter, PM2.5, report-back

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Messenger 1Behavioural

    The first type of messenger (specific details TBD) that will be used to deliver the environmental sampling results.

  • Messenger 2Behavioural

    The second type of messenger (specific details TBD) that will be used to deliver the environmental sampling results.

  • Format 1Behavioural

    The first type of format (specific details TBD) that will be used to deliver the environmental sampling results.

  • Format 2Behavioural

    The second type of format (specific details TBD) that will be used to deliver the environmental sampling results.

Study groups in NCT06593340
Study groupRoleWhat they receive
Real-Time Exposure DataExperimentalParticipants in this arm will get their data reported-back in real-time. There will be a total of 4 different strategies tested based on a combination of two (2) messengers and two (2) formats tested.
Receives: Behavioral: Messenger 1; Behavioral: Messenger 2; Behavioral: Format 1; Behavioral: Format 2
Delayed Exposure DataExperimentalParticipants in this arm will get their data reported-back only after all exposure data are collected (i.e., delayed approximately 2 months). There will be a total of 4 different strategies tested based on a combination of two (2) messengers and two (2) formats tested.
Receives: Behavioral: Messenger 1; Behavioral: Messenger 2; Behavioral: Format 1; Behavioral: Format 2

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Exposure Reduction Behaviors

    This will be collected using a questionnaire with a likert scale from 1 (not at all) to 10 (a lot) of how often certain exposure-reduction behaviors are performed.

    Measured: 3 months after report-back

  2. Exposure Reduction Behaviors

    This will be collected using a questionnaire with a likert scale from 1 (not at all) to 10 (a lot) of how often certain exposure-reduction behaviors are performed.

    Measured: 6 months after report-back

  3. Exposure Reduction Behaviors

    This will be collected using a questionnaire with a likert scale from 1 (not at all) to 10 (a lot) of how often certain exposure-reduction behaviors are performed.

    Measured: 12 months after report-back

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Sep 2024
  2. Study startOct 2026 (estimated)
  3. Primary completionApr 2028 (estimated)
  4. Study completionApr 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
112 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06593340
Sponsor's protocol ID
R01ES036260
Other IDs
R01ES036260
Status last verified
Dec 2025
First submitted
9 Sep 2024
Last updated
12 Dec 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Messenger 1, Messenger 2 and Format 1 in people with Behavior Change, run by University of Utah.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 12 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Darrah K Sleeth, PhD (801-585-3587, darrah.sleeth@hsc.utah.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Exposure Reduction Behaviors (time frame: 3 months after report-back). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Dec 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in